CYP3A4 and tuberculosis: CYP3A4 has been reported to be the isoform most affected in the downregulation of inflammation-related CYPs, which may lead to lower metabolism, longer half-life, and increased plasma concentration of the CYP3A4 substrate drugs used for TB treatment (Lenoir et al., 2021).